IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 35 filers reported holding IBERE PHARMACEUTICALS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $137,000 | +0.7% | 13,850 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $136,000 | -0.7% | 13,850 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $137,000 | -1.4% | 13,850 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $139,000 | +0.7% | 13,850 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $138,000 | -0.7% | 13,850 | 0.0% | 0.01% | +66.7% |
| Q2 2021 | $139,000 | +1.5% | 13,850 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $137,000 | – | 13,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |